State of Tennessee, Department of Treasury’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $637K | Sell |
12,316
-3,174
| -20% | -$162K | ﹤0.01% | 1356 |
|
|
2025
Q4 | $746K | Sell |
15,490
-6,132
| -28% | -$298K | ﹤0.01% | 1291 |
|
|
2025
Q3 | $1.03M | Buy |
21,622
+8,333
| +63% | +$336K | ﹤0.01% | 1184 |
|
|
2025
Q2 | $419K | Hold |
13,289
| – | – | ﹤0.01% | 1444 |
|
|
2025
Q1 | $435K | Hold |
13,289
| – | – | ﹤0.01% | 1439 |
|
|
2024
Q4 | $481K | Sell |
13,289
-5,062
| -28% | -$178K | ﹤0.01% | 1439 |
|
|
2024
Q3 | $572K | Buy |
18,351
+3,629
| +25% | +$113K | ﹤0.01% | 1395 |
|
|
2024
Q2 | $394K | Hold |
14,722
| – | – | ﹤0.01% | 1461 |
|
|
2024
Q1 | $502K | Sell |
14,722
-10,305
| -41% | -$307K | ﹤0.01% | 1388 |
|
|
2023
Q4 | $724K | Sell |
25,027
-1,707
| -6% | -$45.3K | ﹤0.01% | 1292 |
|
|
2023
Q3 | $737K | Sell |
26,734
-3,715
| -12% | -$113K | ﹤0.01% | 1177 |
|
|
2023
Q2 | $915K | Sell |
30,449
-1,226
| -4% | -$42.9K | ﹤0.01% | 1199 |
|
|
2023
Q1 | $1.15M | Buy |
31,675
+240
| +0.8% | +$9.23K | 0.01% | 1055 |
|
|
2022
Q4 | $1.12M | Hold |
31,435
| – | – | 0.01% | 1079 |
|
|
2022
Q3 | $1.06M | Buy |
31,435
+3,371
| +12% | +$110K | 0.01% | 1062 |
|
|
2022
Q2 | $812K | Sell |
28,064
-3,110
| -10% | -$89.1K | ﹤0.01% | 1176 |
|
|
2022
Q1 | $1.01M | Buy |
31,174
+3,045
| +11% | +$93.4K | ﹤0.01% | 1180 |
|
|
2021
Q4 | $820K | Hold |
28,129
| – | – | ﹤0.01% | 1210 |
|
|
2021
Q3 | $751K | Sell |
28,129
-1,816
| -6% | -$48.7K | ﹤0.01% | 1231 |
|
|
2021
Q2 | $922K | Sell |
29,945
-4,767
| -14% | -$146K | ﹤0.01% | 1189 |
|
|
2021
Q1 | $909K | Sell |
34,712
-7,675
| -18% | -$215K | ﹤0.01% | 1155 |
|
|
2020
Q4 | $1.07M | Buy |
42,387
+1,683
| +4% | +$36.2K | ﹤0.01% | 1040 |
|
|
2020
Q3 | $848K | Buy |
40,704
+1,435
| +4% | +$32.6K | ﹤0.01% | 1003 |
|
|
2020
Q2 | $933K | Buy |
39,269
+4,053
| +12% | +$89.5K | ﹤0.01% | 988 |
|
|
2020
Q1 | $633K | Sell |
35,216
-4,469
| -11% | -$93.9K | ﹤0.01% | 1040 |
|
|
2019
Q4 | $941K | Sell |
39,685
-2,375
| -6% | -$57.7K | ﹤0.01% | 1073 |
|
|
2019
Q3 | $1.16M | Buy |
42,060
+4,235
| +11% | +$125K | 0.01% | 1007 |
|
|
2019
Q2 | $1.25M | Sell |
37,825
-1,998
| -5% | -$68.5K | 0.01% | 949 |
|
|
2019
Q1 | $1.4M | Buy |
39,823
+1,453
| +4% | +$54.1K | 0.01% | 927 |
|
|
2018
Q4 | $1.27M | Buy |
38,370
+2,238
| +6% | +$96.2K | 0.01% | 903 |
|
|
2018
Q3 | $1.82M | Buy |
36,132
+1,111
| +3% | +$54.9K | 0.01% | 854 |
|
|
2018
Q2 | $2.1M | Sell |
35,021
-1,224
| -3% | -$63.4K | 0.01% | 802 |
|
|
2018
Q1 | $1.66M | Sell |
36,245
-3,806
| -10% | -$159K | 0.01% | 862 |
|
|
2017
Q4 | $1.6M | Sell |
40,051
-4,361
| -10% | -$172K | 0.01% | 922 |
|
|
2017
Q3 | $1.78M | Sell |
44,412
-1,967
| -4% | -$85.1K | 0.01% | 882 |
|
|
2017
Q2 | $2M | Hold |
46,379
| – | – | 0.01% | 851 |
|
|
2017
Q1 | $1.45M | Buy |
46,379
+6,999
| +18% | +$188K | 0.01% | 988 |
|
|
2016
Q4 | $994K | Hold |
39,380
| – | – | 0.01% | 1114 |
|
|
2016
Q3 | $974K | Buy |
39,380
+12,650
| +47% | +$286K | ﹤0.01% | 1046 |
|
|
2016
Q2 | $544K | Hold |
26,730
| – | – | ﹤0.01% | 1218 |
|
|
2016
Q1 | $408K | Buy |
26,730
+630
| +2% | +$8.22K | ﹤0.01% | 1259 |
|
|
2015
Q4 | $351K | Buy |
+26,100
| New | +$404K | ﹤0.01% | 1290 |
|
|
2015
Q3 | – | Sell |
-23,000
| Closed | -$391K | – | 1182 |
|
|
2015
Q2 | $391K | Buy |
+23,000
| New | +$327K | ﹤0.01% | 1300 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
State of Tennessee, Department of Treasury's SUPN Position: Q1 2026 in Review
State of Tennessee, Department of Treasury reduced its Supernus Pharmaceuticals (SUPN) stake by 20% in Q1 2026, selling an estimated $162K and leaving 12,316 shares worth $637K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.
State of Tennessee, Department of Treasury first reported a position in SUPN in Q2 2015 and has held it in 43 quarters since. The position peaked at $2.1M in Q2 2018. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- State of Tennessee, Department of Treasury held 12,316 shares of Supernus Pharmaceuticals worth $637K as of Q1 2026.
- State of Tennessee, Department of Treasury sold 3,174 Supernus Pharmaceuticals shares in Q1 2026, an estimated $162K.
- Supernus Pharmaceuticals made up ﹤0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #1356 holding.
- State of Tennessee, Department of Treasury first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 43 quarters since.
- State of Tennessee, Department of Treasury's Supernus Pharmaceuticals position peaked at $2.1M in Q2 2018.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.